XenoTherapeutics is a clinical-stage biotechnology research and development company developing personalized cells, tissues, and organs to provide regenerative medicine solutions that treat common and rare diseases. We conduct all phases of clinical product development including multiplex genomic engineering, prototype design and evaluation, cGMP manufacturing, and pre-and-clinical stage product evaluation.Our FDA-grade donor animals provide a robust platform of therapies to meet several unmet medical needs. Our first clinical success is Xeno-Skin, closely followed by Xeno-Nerve, and several more breakthrough solutions on the horizon.